Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
Brittney H CottaMargaret F MeagherDattatraya H PatilKazutaka SaitoSunil H PatelDevin N PatelNathan MillerRaksha DuttCathrine KeinerAaron W BradshawFang WanAhmed EldefrawyYosuke YasudaYasuhisa FujiiViraj MasterIthaar H DerweeshPublished in: BJU international (2020)
Pre-treatment elevated CRP was independently associated with both progressive renal functional decline and NCM in patients undergoing surgery for Stage 1-2 RCC. Patients with elevated CRP and Stage 1 and 2 RCC may be considered as having indication for nephron-sparing strategies, which may be prioritised if oncologically appropriate.